If you have tried to eat less and move more and still feel stuck, you are not alone. Your body has strong signals that defend your current weight. MEDVi uses a GLP-1 weight loss program to work with those signals, not against them. Here is the science in plain words.
GLP-1, the hormone that changes appetite and metabolism
GLP-1 stands for glucagon like peptide 1. Your gut releases it after you eat. It communicates with the brain, stomach, and pancreas.
In the brain, it helps quiet hunger signals so food thoughts do not push you all day.
In the stomach, it slows gastric emptying so meals last longer and you feel satisfied on less.
In the pancreas, it boosts insulin when you eat and lowers glucagon, which steadies blood sugar after meals.
These three actions together help you eat fewer calories without the constant struggle, and help your body use energy more efficiently.
Medications that mimic GLP-1
MEDVi pairs you with prescription-strength GLP-1 medications that mimic this natural signal.
Semaglutide is a GLP-1 analog.
Tirzepatide targets GLP-1 and GIP, two gut hormones linked to appetite and blood sugar.
You can take these as a weekly injection or as daily GLP-1 tablets. The effect is similar in goal, fewer cravings, smaller portions, and steadier post meal energy. In some plans, compounded semaglutide is used to keep costs within reach while following strict quality standards.
Why this helps real people lose real weight?
Traditional dieting often triggers a fight back from your biology. Hunger hormones rise, metabolism slows, and you feel tired and distracted by food. GLP-1 medication lowers those hunger drives, slows the pace of the stomach, and improves glucose control. You can keep a calorie deficit without feeling like each day is a battle. Over time, this can reset the pattern that held your body at a higher weight.
What studies show?
Large clinical trials of GLP-1 and dual GLP-1 GIP drugs show average losses in the 10 to 20% range of starting body weight over time. In practice, that means a 250 pound person often loses about 25 to 50 pounds, sometimes more, with steady use and basic habits. These outcomes are well above typical diet and exercise programs that average around 5 percent. MEDVi’s own reporting lines up with that range, which is why many users see changes in clothes, waist size, and daily comfort within the first few months.
How do we turn the science into a simple plan?
The Medvi patient portal guides you step by step.
You choose a format that fits your life, a weekly injection or a daily tablet.
You start low and follow a titration schedule to help your body adapt.
You log weight, appetite cues, sleep, and simple habits to see progress.
If mild issues arise, like queasy feelings or constipation, you get quick fixes, gradual dose adjustments, and reminders about hydration and meal timing.
This is telehealth weight loss that removes friction. Your home-delivered weight-loss meds arrive with clear instructions. You always see MEDVi pricing and what is included before you pay.
What people report as they go?
Members often share the same early wins.
Grocery trips feel calmer, and snacks lose their pull.
Meals are satisfied with less, and spacing meals becomes easier.
Energy through the afternoon is more even, which helps with focus.
As body weight drops, many notice better sleep and confidence.
These non scale wins matter because they help you stay consistent long enough to reach the bigger goal.
Safety, screening, and smart dosing
Any real medication can cause side effects, so care and pacing matter. Common effects are mild and usually short, such as nausea, burping, indigestion, or constipation in the early weeks. Slower dose steps, small meals, extra fluids, and light activity often solve them. Serious risks are uncommon but include past pancreatitis or a rare thyroid cancer history in the family. Pregnant or nursing women should not use GLP-1. Screening happens up front to keep you safe. If a compounded option is not a fit for you, that path is not used.
Why is this different from a supplement
This is not a quick-fix pill from a store shelf. GLP-1 medicines are manufactured to act on specific receptors in your brain and gut. They copy a signal your body already makes, which is why people feel more in control rather than wired or jittery. That is also why results hold when you follow the plan. You are working with biology, not fighting it.
What this means for your next six months
If you start now and follow your plan, you can expect a clear pattern.
Weeks 1 to 4: learning your dose day or tablet routine and basic meal timing.
Months 2 to 3: steady drops on the scale and smaller portions without strain.
Months 4 to 6: visible changes in waist and photos, easier movement, more confidence in daily life.
Your exact pace is your own, but the pathway is proven. You can see your live offer, confirm MEDVi pricing, and begin the eligibility quiz in minutes. The science is solid, the plan is simple, and the support is there when you need it.
Important Disclosure and Medical Information
Affiliate Relationship Disclosure
They are independent affiliates who promote MEDVi products because they believe in their potential benefits. They have no ownership stake, operational control, or direct business relationship with MEDVi beyond our affiliate partnership. Our recommendations are based on our research and belief in the product’s value, but they are not employees, partners, or representatives of MEDVi.
Medical Assessment and Provider Information
The assessment available through MEDVi does not establish a doctor-patient relationship between individuals and MEDVi. OpenLoop Health, an independent network of US-licensed physicians following strict medical protocols for patient safety, has developed screening criteria to determine GLP-1 medication eligibility. Individual responses to the MEDVi assessment determine preliminary screening results, and OpenLoop Health clinicians conduct final reviews after checkout to make prescription decisions. All prescribing decisions remain at the sole discretion of OpenLoop Health medical providers.
Treatment Results and Disclaimers
All effectiveness claims and benefits referenced on this site are based on self-reported customer data from individuals following comprehensive treatment plans that include compounded GLP-1 medications and ongoing medical consultations. Customers self-reported weight measurements during initial medical intake and every 3-4 weeks thereafter. Individual results with compounded medications available through MEDVi may vary significantly and depend on program adherence and following clinician recommendations.
Medication Safety Information
Compounded GLP-1 medications are manufactured in FDA-regulated facilities that maintain high regulatory standards. However, these compounded medications have not received FDA approval and have not undergone FDA evaluation for safety, efficacy, or quality. Licensed healthcare providers make compounded medication decisions based on their medical judgment, informed by telehealth consultations and comprehensive medical histories.
They strongly encourage anyone considering compounded medications to discuss specific risks and benefits with their healthcare provider. MEDVi does not manufacture compounded medications, and actual medication appearance may differ from website imagery.
Pharmacy Partnership
MEDVi partners with Belmar Pharmacy to provide products and services to members. Regular communication occurs regarding product availability, shipping schedules, and medication testing updates. Belmar Pharmacy | Phone: 800-525-9473 | belmarpharmasolutions.com/
Expected Results
Results vary based on starting weight and program adherence. Reported measurements include inches lost from hips, waist, chest, thighs and arms within the first month. Featured users maintained daily exercise routines and followed reduced-calorie diets. Their fat loss results are not typical, and individual results may vary. Medication prescriptions require medical provider approval and may not be appropriate for all individuals. MEDVi programs typically produce 1-2 pounds per week weight loss over 4 weeks when combined with healthy dietary changes and exercise modifications. Always consult healthcare professionals before beginning medication or weight loss programs.
Clinical trial data shows average weight loss from three 68-week studies involving patients without diabetes who achieved and maintained 2.4 mg/week GLP-1 treatment doses, combined with reduced-calorie diets and increased physical activity.
Program and Medication Information
Medication costs are included in MEDVi Program pricing. Wegovy® has FDA approval for weight loss treatment. Ozempic® has FDA approval for type 2 diabetes management but may be prescribed off-label for weight loss. All trademarks, service marks, and trade names (Wegovy®, Ozempic®) displayed remain the property of their respective owners. Medical treatment services are provided by “CareGLP Affiliated P.C.s” and OpenLoop Health, which operate as affiliated networks for medical professional corporations and associations.
Truspilot: 4.4 / 5 Star ****